University of Rochester - Pharmaceuticals & Healthcare - Deals and Alliances Profile
September 2018
28
About the Report
About the Report
Summary
University of Rochester (UOR) is an educational university that offers research and development services. The university performs research in the areas of humanities, engineering medical education, medicine, geology, optics, economics, political theory, human behavior, and social and natural sciences. It offers various programs such as actuarial studies, American Sign Language, American studies, anthropology, applied mathematics, Arabic minor, art history, biological sciences, computational biology, and biotechnology, among others. The university owns and maintains Eastman School of Music, School of Medicine and Dentistry, School of Nursing, School of Arts and Sciences, Hajim School of Engineering and Applied Sciences, Simon Business School and Warner School of Education. UOR is headquartered in Rochester, New York, the US.
University of Rochester-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Products
University of Rochester, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
University of Rochester, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
University of Rochester, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
University of Rochester, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
University of Rochester, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
University of Rochester, Medical Devices Deals, 2012 to YTD 2018 9
University of Rochester, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
University of Rochester, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Taithera Plans to Enter into Distribution Agreement with University of Rochester for Bone-Targeted Therapeutic Agent 11
University of Rochester Medical Center Partners with Indivumed 12
Qu Biologics Enters into Research Agreement with University of Rochester 13
Licensing Agreements 14
Vivione Biosciences Enters into Licensing Agreement with University of Rochester 14
Panther Biotech Enters into Licensing Agreement with University of Rochester 15
MiniVax Enters Into Option For Licensing Agreement With University of Rochester 16
University of Rochester-Key Competitors 17
University of Rochester-Key Employees 18
University of Rochester-Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Government and Public Interest 20
Jul 18, 2018: St. Baldrick's foundation announces USD 19.1 million in grants to fund lifesaving childhood cancer research 20
Nov 16, 2017: Telephus Medical Founder Awarded USD 6 Million NIH Grant to Expand Translational Research in Bone Infections 21
Jul 26, 2017: Gene Therapy to Correct Surfactant Protein B Deficiency in Newborns 22
Jul 26, 2017: University of Rochester Awarded USD 19 Million to Coordinate National Clinical and Translational Science Program 23
Other Significant Developments 25
Jul 26, 2018: Desperately ill patients will get better access to experimental treatments through new effort 25
Aug 16, 2017: Radiation Oncology begins Metastatic Cancer & Palliative Care service 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28
List of Figure
List of Figures
University of Rochester, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
University of Rochester, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
University of Rochester, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
University of Rochester, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
University of Rochester, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
University of Rochester, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
University of Rochester, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
University of Rochester, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
University of Rochester, Medical Devices Deals, 2012 to YTD 2018 9
List of Table
List of Tables
University of Rochester, Pharmaceuticals & Healthcare, Key Facts 2
University of Rochester, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
University of Rochester, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
University of Rochester, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
University of Rochester, Deals By Therapy Area, 2012 to YTD 2018 8
University of Rochester, Medical Devices Deals, 2012 to YTD 2018 9
University of Rochester, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Taithera Plans to Enter into Distribution Agreement with University of Rochester for Bone-Targeted Therapeutic Agent 11
University of Rochester Medical Center Partners with Indivumed 12
Qu Biologics Enters into Research Agreement with University of Rochester 13
Vivione Biosciences Enters into Licensing Agreement with University of Rochester 14
Panther Biotech Enters into Licensing Agreement with University of Rochester 15
MiniVax Enters Into Option For Licensing Agreement With University of Rochester 16
University of Rochester, Key Competitors 17
University of Rochester, Key Employees 18
University of Rochester, Other Locations 19
University of Rochester, Subsidiaries 19
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.